# ReShape Lifesciences, Inc. – FDA Inspection, Dec 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/feb5d6d2-62f7-407c-accc-83f1f06b20bc
Source feed: FDA_Inspections

> FDA inspection 1036574 of ReShape Lifesciences, Inc., December 18, 2017. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR parts 803 and 820. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036574
- Company Name: ReShape Lifesciences, Inc.
- Inspection Date: 2017-12-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 7

## Related Documents

- [FDA Inspection 1091756 - 2019-05-22](https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/e4e54b6b-de8f-410c-9f4c-67b3c01d41f9)
- FDA Inspection 974242 - 2016-04-22
- [FDA Inspection 856112 - 2013-11-25](https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/990239b7-09ea-419b-9b89-911122298ba3)
- FDA Inspection 838101 - 2013-06-17

## Related Officers

- [Company Rep](https://www.keypedia.com/people/susan-m-matthias/cd23c465-4411-4988-8676-2089e265622a)

Company: https://www.keypedia.com/companies/reshape-lifesciences-inc/740415bf-ee64-46b0-91ff-3ff435f3769d

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7